Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.granulesindia.com | |
Market Cap | 9,409.97 Cr. | |
Enterprise Value(EV) | 10,383.03 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 16.25 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 23.89 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 38.52 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 122.43 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 3.17 | Calculated using Price: 388.25 |
Dividend Yield | 0.39 | Period Ending 2023-03 |
No. of Shares Subscribed | 24.24 Cr. | 242,368,716 Shares |
FaceValue | 1 | |
About Granules India Ltd. | ||
Granules India is one of the vertically integrated, high-growth pharmaceutical manufacturing company in India today. Based out of Hyderabad, India, it is into manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediaries (PFIs) and Finished Dosages (FDs). |
1 Day |
|
-1.75% |
1 Week |
|
-2.85% |
1 Month |
|
+9.57% |
3 Month |
|
+22.77% |
6 Month |
|
+36.83% |
1 Year |
|
+16.05% |
2 Year |
|
+27.02% |
5 Year |
|
+360.83% |
10 Year |
|
+2042.66% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 23.29 | 23.53 | 18.23 | 10.60 | 13.32 | 18.54 | 27.64 | 17.49 | 19.18 | |
Return on Capital Employed (%) | 18.81 | 20.16 | 16.57 | 11.09 | 12.71 | 17.22 | 25.42 | 17.37 | 19.63 | |
Return on Assets (%) | 8.28 | 9.03 | 8.12 | 5.13 | 6.64 | 9.99 | 15.84 | 10.04 | 10.97 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 431 | 662 | 904 | 1,304 | 1,529 | 1,844 | 2,173 | 2,587 | 2,835 | 2,967 | |
Non Curr. Liab. | 357 | 247 | 188 | 488 | 553 | 486 | 366 | 283 | 255 | 215 | |
Curr. Liab. | 415 | 655 | 787 | 878 | 896 | 893 | 1,173 | 1,642 | 1,814 | 2,069 | |
Minority Int. | 1 | ||||||||||
Equity & Liab. | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,223 | 3,713 | 4,512 | 4,903 | 5,252 | |
Non Curr. Assets | 700 | 745 | 1,051 | 1,484 | 1,696 | 1,594 | 1,716 | 2,007 | 2,329 | 2,459 | |
Curr. Assets | 500 | 818 | 828 | 1,187 | 1,282 | 1,629 | 1,997 | 2,505 | 2,574 | 2,792 | |
Misc. Exp. not W/O | 3 | ||||||||||
Total Assets | 1,203 | 1,563 | 1,879 | 2,670 | 2,979 | 3,223 | 3,713 | 4,512 | 4,903 | 5,252 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1,294 | 1,357 | 1,411 | 1,685 | 2,279 | 2,599 | 3,238 | 3,765 | 4,512 | 4,517 | |
Other Income | 4 | 6 | 10 | 11 | 27 | 37 | 27 | 18 | 14 | 6 | |
Total Income | 1,297 | 1,363 | 1,420 | 1,695 | 2,306 | 2,635 | 3,264 | 3,783 | 4,526 | 4,523 | |
Total Expenditure | -1,084 | -1,081 | -1,112 | -1,406 | -1,895 | -2,073 | -2,382 | -3,043 | -3,599 | -3,707 | |
PBIDT | 213 | 282 | 309 | 289 | 411 | 562 | 882 | 740 | 928 | 815 | |
Interest | -32 | -37 | -32 | -33 | -28 | -27 | -26 | -23 | -56 | -84 | |
Depreciation | -53 | -58 | -72 | -76 | -105 | -137 | -151 | -159 | -184 | -199 | |
Taxation | -37 | -61 | -65 | -63 | -89 | -116 | -155 | -145 | -171 | -138 | |
Exceptional Items | 28 | ||||||||||
PAT | 91 | 125 | 140 | 117 | 188 | 310 | 549 | 413 | 517 | 394 | |
Minority Interest | |||||||||||
Share Associate | -2 | 25 | 16 | 49 | 25 | ||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 91 | 123 | 165 | 133 | 236 | 335 | 549 | 413 | 517 | 394 | |
Adjusted EPS | 4 | 6 | 7 | 5 | 9 | 13 | 22 | 17 | 21 | 16 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 108 | 150 | 151 | 188 | -1 | 262 | 476 | 432 | 332 | 739 | |
Cash Fr. Inv. | -255 | -146 | -162 | -326 | -462 | -270 | -161 | -277 | -380 | -191 | |
Cash Fr. Finan. | 147 | 19 | 86 | 56 | 529 | -17 | -213 | -299 | 190 | -440 | |
Net Change | 0 | 24 | 75 | -82 | 66 | -25 | 103 | -144 | 142 | 107 | |
Cash & Cash Eqvt | 42 | 65 | 130 | 42 | 108 | 83 | 186 | 42 | 185 | 292 |
Mon, 27 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Schedule of Analyst/ Investor Meet |
Thu, 23 Nov 2023
Disclosure Of Information Under The Regulation 30 Of The SEBI (LODR) Regulations 2015 Disclosure of information under the Regulation 30 of the SEBI (LODR) Regulations 2015 |
Thu, 16 Nov 2023
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of Schedule of the Analyst/Investor Meeting |
Fri, 08 Dec 2023 |
|
|
|
|
|